Cargando…
A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid
BACKGROUND: Avidity determination of antigen-specific immunoglobulin G (IgG) antibodies is an established serological method to differentiate acute from past infections. In order to compare the avidity of varicella-zoster virus (VZV) IgG in pairs of serum and cerebrospinal fluid (CSF) samples, we de...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522815/ https://www.ncbi.nlm.nih.gov/pubmed/15355548 http://dx.doi.org/10.1186/1471-2334-4-33 |
_version_ | 1782121853240737792 |
---|---|
author | Kneitz, Ralf-Herbert Schubert, Jörg Tollmann, Franz Zens, Wolfgang Hedman, Klaus Weissbrich, Benedikt |
author_facet | Kneitz, Ralf-Herbert Schubert, Jörg Tollmann, Franz Zens, Wolfgang Hedman, Klaus Weissbrich, Benedikt |
author_sort | Kneitz, Ralf-Herbert |
collection | PubMed |
description | BACKGROUND: Avidity determination of antigen-specific immunoglobulin G (IgG) antibodies is an established serological method to differentiate acute from past infections. In order to compare the avidity of varicella-zoster virus (VZV) IgG in pairs of serum and cerebrospinal fluid (CSF) samples, we developed a new technique of avidity testing, the results of which are not influenced by the concentration of specific IgG. METHODS: The modifications introduced for the new VZV IgG avidity method included the use of urea hydrogen peroxide as denaturing reagent, the adaptation of the assay parameters in order to increase the sensitivity for the detection of low-level VZV IgG in CSF, and the use of a new calculation method for avidity results. The calculation method is based on the observation that the relationship between the absorbance values of the enzyme immunoassays with and without denaturing washing step is linear. From this relationship, a virtual absorbance ratio can be calculated. To evaluate the new method, a panel of serum samples from patients with acute and past VZV infection was tested as well as pairs of serum and CSF. RESULTS: For the serum panel, avidity determination with the modified assay gave results comparable to standard avidity methods. Based on the coefficient of variation, the new calculation method was superior to established methods of avidity calculation. CONCLUSIONS: The new avidity method permits a meaningful comparison of VZV IgG avidity in serum and CSF and should be of general applicability for easy determination of avidity results, which are not affected by the concentration of specific IgG. |
format | Text |
id | pubmed-522815 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-5228152004-10-17 A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid Kneitz, Ralf-Herbert Schubert, Jörg Tollmann, Franz Zens, Wolfgang Hedman, Klaus Weissbrich, Benedikt BMC Infect Dis Technical Advance BACKGROUND: Avidity determination of antigen-specific immunoglobulin G (IgG) antibodies is an established serological method to differentiate acute from past infections. In order to compare the avidity of varicella-zoster virus (VZV) IgG in pairs of serum and cerebrospinal fluid (CSF) samples, we developed a new technique of avidity testing, the results of which are not influenced by the concentration of specific IgG. METHODS: The modifications introduced for the new VZV IgG avidity method included the use of urea hydrogen peroxide as denaturing reagent, the adaptation of the assay parameters in order to increase the sensitivity for the detection of low-level VZV IgG in CSF, and the use of a new calculation method for avidity results. The calculation method is based on the observation that the relationship between the absorbance values of the enzyme immunoassays with and without denaturing washing step is linear. From this relationship, a virtual absorbance ratio can be calculated. To evaluate the new method, a panel of serum samples from patients with acute and past VZV infection was tested as well as pairs of serum and CSF. RESULTS: For the serum panel, avidity determination with the modified assay gave results comparable to standard avidity methods. Based on the coefficient of variation, the new calculation method was superior to established methods of avidity calculation. CONCLUSIONS: The new avidity method permits a meaningful comparison of VZV IgG avidity in serum and CSF and should be of general applicability for easy determination of avidity results, which are not affected by the concentration of specific IgG. BioMed Central 2004-09-08 /pmc/articles/PMC522815/ /pubmed/15355548 http://dx.doi.org/10.1186/1471-2334-4-33 Text en Copyright © 2004 Kneitz et al; licensee BioMed Central Ltd. |
spellingShingle | Technical Advance Kneitz, Ralf-Herbert Schubert, Jörg Tollmann, Franz Zens, Wolfgang Hedman, Klaus Weissbrich, Benedikt A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid |
title | A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid |
title_full | A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid |
title_fullStr | A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid |
title_full_unstemmed | A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid |
title_short | A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid |
title_sort | new method for determination of varicella-zoster virus immunoglobulin g avidity in serum and cerebrospinal fluid |
topic | Technical Advance |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522815/ https://www.ncbi.nlm.nih.gov/pubmed/15355548 http://dx.doi.org/10.1186/1471-2334-4-33 |
work_keys_str_mv | AT kneitzralfherbert anewmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid AT schubertjorg anewmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid AT tollmannfranz anewmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid AT zenswolfgang anewmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid AT hedmanklaus anewmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid AT weissbrichbenedikt anewmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid AT kneitzralfherbert newmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid AT schubertjorg newmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid AT tollmannfranz newmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid AT zenswolfgang newmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid AT hedmanklaus newmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid AT weissbrichbenedikt newmethodfordeterminationofvaricellazostervirusimmunoglobulingavidityinserumandcerebrospinalfluid |